Table 1 Expression level of CELF1 in lung carcinoma and relationship to clinicopathological parameters
From: Si-RNA mediated knockdown of CELF1 gene suppressed the proliferation of human lung cancer cells
Variable | Case no. | CELF1 expression (RQ: 2-ΔΔCT) | P value | |
|---|---|---|---|---|
Median | Mean ± SEM | |||
Gender | ||||
Male | 41 | 1.1090 | 1.2458 ± 0.9115 | 0.183 |
Female | 12 | 0.7252 | 0.8938 ± 103.53 | |
Age | ||||
≤ 60.5 | 32 | 0.9000 | 1.0103 ± 0.8746 | 0.118 |
> 60.5 | 21 | 0.1164 | 1.4035 ± 1.4948 | |
Venous invasion | ||||
Negative | 40 | 1.0274 | 1.2302 ± 1.2217 | 0.251 |
Positive | 13 | 0.5492 | 0.9687 ± 0.9781 | |
T stage | ||||
T1 | 7 | 1.5105 | 1.396 ± 1.1033 | 0.041 |
T2 | 21 | 1.2776 | 1.5178 ± 1.2898 | |
T3 | 17 | 0.6242 | 0.8040 ± 0.7079 | |
T4 | 8 | 0.3816 | 0.8109 ± 1.4910 | |
N stage | ||||
N0 | 25 | 0.6242 | 0.9983 ± 1.1184 | 0.251 |
N1 | 11 | 1.3165 | 1.4731 ± 1.4334 | |
N2 | 17 | 1.1164 | 1.2142 ± 1.0611 | |
Lymph node status | ||||
N0 | 25 | 0.6242 | 0.9983 ± 1.1184 | 0.164 |
N1 + N2 | 28 | 1.2321 | 1.3159 ± 1.2020 | |
TNM stage | ||||
Ia | 4 | 1.2109 | 1.4055 ± 1.3481 | 0.089 |
Ib | 6 | 1.2500 | 1.4397 ± 0.9834 | |
IIa | 5 | 1.3322 | 2.1861 ± 1.7131 | |
IIb | 13 | 0.6242 | 0.7331 ± 0.5595 | |
IIIa | 23 | 0.6624 | 1.1535 ± 1.2526 | |
IIIb | 2 | 0.2747 | 0.2747 ± 0.3882 | |
Differentiation | ||||
Well | 6 | 1.0545 | 0.8122 ± 0.5568 | 0.256 |
Moderate | 28 | 0.9000 | 1.1866 ± 1.1315 | |
Poor | 19 | 1.0548 | 1.2476 ± 1.3613 | |
Compared case | ||||
Tumor tissue | 10 | 1.5263 | 1.9005 ± 1.4382 | 0.012 |
Normal tissue | 10 | 0.2509 | 0.4579 ± 0.4761 | |